Insufflation Device Market Size, Share & Trends Analysis | Global | 2026-2032 | Includes: Insufflator, Veress Needle Markets, and 1 more

Global Insufflation Device Market Report to 2032

The global insufflation device market was valued at slightly below $600 million in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 3.4%, reaching over $750 million by 2032.

This comprehensive report covers the global market for insufflation devices, including insufflator consoles, insufflation tubing and Veress needles used across laparoscopic procedures.

The analysis includes unit sales, average selling prices (ASPs), market size, growth trends, market drivers and limiters, market forecasts through 2032, and historical data back to 2022. It also includes recent mergers and acquisitions, company profiles, product portfolios and leading competitors.

Growth in this market is supported by continued laparoscopic procedure volumes and replacement demand for insufflation systems with advanced features. Integrated smoke evacuation and filtration capabilities are expected to support incremental growth as hospitals place greater focus on surgical smoke safety.

Market Overview

The global insufflation device market includes the systems and accessories used to create and maintain pneumoperitoneum during laparoscopic surgery. These products are essential to minimally invasive procedures because they provide the working space surgeons need to visualize anatomy and operate safely.

The market includes insufflator consoles, insufflation tubing and Veress needles. Insufflators control gas flow and pressure, tubing connects the gas source to the patient interface, and Veress needles are used in closed-entry techniques to establish pneumoperitoneum.

Insufflation devices are used across general surgery, gynecology and urology. Demand is closely tied to laparoscopic procedure volumes, hospital replacement cycles and the continued role of laparoscopy as a standard minimally invasive surgical approach in global healthcare systems.

Market growth is expected to remain steady and replacement driven. While the market is mature, new systems with higher flow rates, adaptive pressure control, heating and smoke management features provide reasons for hospitals to upgrade existing equipment when clinical or operational benefits are clear.

Market Drivers

Laparoscopic procedure volume remains a core driver of the global insufflation device market. Laparoscopy is one of the most commonly performed minimally invasive techniques worldwide and offers faster recovery, shorter hospital stays, reduced post-operative complications and lower overall surgical risk compared to open surgery.

Because laparoscopic techniques remain central to surgical training and clinical practice, demand for insufflation systems is supported by high procedural volumes. Even as robotic-assisted surgery expands, traditional laparoscopy remains the clinical and economic standard of care across most healthcare systems, sustaining baseline demand for insufflation devices.

Technological development is also supporting market growth. Replacement demand is being driven by insufflation systems with higher flow rates, adaptive pressure control and integrated heating capabilities. Growing awareness of surgical smoke exposure has also increased interest in multifunctional insufflation platforms that include smoke evacuation or filtration features.

Market Limiters

The continued use of the Hasson, or open, technique limits growth in the Veress needle segment. In patients with prior abdominal surgery or higher risk of access-related complications, surgeons may prefer trocar-based entry instead of Veress needle insufflation.

As a result, Veress needle adoption remains constrained even when laparoscopic procedure volumes are stable. This creates a segment-specific limiter within the broader insufflation device market, especially in settings where open-entry techniques are commonly preferred.

Market maturity is another important limiter. The insufflator market is largely driven by replacement sales rather than new adoption. Hospitals often retain insufflators for extended periods unless new systems offer clear clinical or operational advantages. Without strong differentiation, replacement cycles may lengthen, limiting unit growth and moderating overall market expansion.

Market Coverage and Data Scope

• Quantitative coverage: Market size, market shares, market forecasts, market growth rates, units sold and average selling prices.
• Qualitative coverage: Market drivers and limiters, market size and growth trends, recent mergers and acquisitions, company profiles, product portfolios and leading competitors.
• Time frame: Base year 2025, forecasts to 2032, and historical data back to 2022.
• Data types included: Unit sales, average selling prices, market size and growth trends, market drivers and limiters, market forecasts through 2032, historical data, recent mergers and acquisitions, company profiles and product portfolios.
• Method note: Market revenue is modeled using unit sales and average selling prices, with segmentation by device type used to assess demand across insufflator consoles, insufflation tubing and Veress needles.

The report is designed to help readers evaluate how laparoscopic procedure volumes, replacement cycles, smoke management requirements and access technique preferences are shaping the global insufflation device market.

Markets Covered and Segmentation

Insufflation Device Market

• Device type: Insufflator, insufflation tubing and Veress needle.

Insufflator consoles are used to regulate gas flow and pressure during laparoscopic procedures.

Insufflation tubing supports gas delivery between the insufflation system and the patient interface.

Veress needles are used in closed-entry techniques to establish pneumoperitoneum before laparoscopic access.

Each segment is analyzed through relevant quantitative measures, including market size, market shares, market forecasts, market growth rates, units sold and average selling prices.

Competitive Analysis

Karl Storz continued to lead the global insufflation device market in 2025. The company was the second-leading competitor in North America and the leading competitor in Western Europe. Its ENDOFLATOR(R) and THERMOFLATOR(R) products are among the most commonly used insufflators on the market, supporting the company's strong global position.

Stryker was the second-leading competitor globally. The company led the North American market and maintained a strong presence in Latin America and Asia. Stryker's broader minimally invasive surgery and operating room portfolio supports its position in insufflation, especially among hospitals seeking integrated surgical technology solutions.

CONMED was the third-leading competitor in the global insufflation device market. The company's AirSeal units offer advanced features, including smoke evacuation, heating and warning functions that alert operators to gas leaks and system failures. These capabilities position CONMED well in facilities seeking multifunctional insufflation platforms that support both pneumoperitoneum stability and surgical smoke management.

Technology and Practice Trends

Advanced insufflation systems are increasingly focused on maintaining stable pneumoperitoneum during surgery. Improved pressure control can help support procedural consistency and reduce interruptions caused by gas loss or pressure fluctuations.

Higher flow rates are also important in modern insufflation systems. These features can help maintain the surgical working space during procedures that involve frequent instrument exchanges or higher leakage risk.

Integrated heating capabilities remain relevant because they can improve gas conditioning during laparoscopic procedures. These systems are designed to support procedural comfort and efficiency by improving the way gas is delivered during surgery.

Smoke evacuation and filtration features are becoming more important. Surgical smoke exposure is receiving more attention from hospitals, clinicians and safety teams, which is supporting interest in insufflators and tubing that help manage smoke during minimally invasive procedures.

Insufflation tubing is also evolving as part of broader smoke management workflows. Tubing with filtration or evacuation capabilities can add value beyond basic gas delivery, especially in facilities updating safety standards.

Veress needles remain part of the market, but their growth is limited by surgeon preference and entry technique. In certain patients, especially those with prior abdominal surgery, clinicians may prefer open or trocar-based entry methods.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

How large is the global insufflation device market, and how is it expected to grow through 2032?

How are insufflator consoles, insufflation tubing and Veress needles performing across global laparoscopic procedures?

How are unit sales, average selling prices and market values changing over time?

How do laparoscopic procedure volumes support baseline demand for insufflation devices?

Which advanced features are driving replacement demand, including higher flow rates, adaptive pressure control, heating and smoke management?

How is growing awareness of surgical smoke exposure affecting product development and purchasing decisions?

How does continued use of the Hasson technique limit Veress needle growth?

Which companies lead the insufflation device market, and how are Karl Storz, Stryker and CONMED positioned?

The Global Insufflation Device Market Report from iData Research answers these questions with detailed market sizing, ASP trends, forecasts and competitive share insights. Use it to evaluate demand, benchmark leading competitors, assess replacement cycle pressure and plan for growth across the global insufflation device market.